GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Elevai Labs Inc (NAS:ELAB) » Definitions » Price-to-Owner-Earnings

ELAB (Elevai Labs) Price-to-Owner-Earnings : (As of Dec. 15, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Elevai Labs Price-to-Owner-Earnings?

As of today (2024-12-15), Elevai Labs's share price is $2.29. Elevai Labs does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Elevai Labs's Price-to-Owner-Earnings or its related term are showing as below:


ELAB's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 31.405
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-12-15), Elevai Labs's share price is $2.29. Elevai Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-59.16. Therefore, Elevai Labs's PE Ratio (TTM) for today is At Loss.

As of today (2024-12-15), Elevai Labs's share price is $2.29. Elevai Labs's EPS without NRI for the trailing twelve months (TTM) ended in was $-62.32. Therefore, Elevai Labs's PE Ratio without NRI for today is At Loss.


Elevai Labs Price-to-Owner-Earnings Historical Data

The historical data trend for Elevai Labs's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elevai Labs Price-to-Owner-Earnings Chart

Elevai Labs Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - -

Elevai Labs Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Elevai Labs's Price-to-Owner-Earnings

For the Biotechnology subindustry, Elevai Labs's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elevai Labs's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Elevai Labs's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Elevai Labs's Price-to-Owner-Earnings falls into.



Elevai Labs Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Elevai Labs's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=2.29/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elevai Labs  (NAS:ELAB) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Elevai Labs Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Elevai Labs's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Elevai Labs Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
120 Newport Center Drive, Suite. 250, Newport Beach, CA, USA, 92660
Elevai Labs Inc is a California-based physician-dispensed skincare company with a focus on modernizing aesthetic skincare. It has commercialized ELEVAI Exosomes a next-generation, patent-pending technology used in its ELEVAI flagship products.